MediciNova
MNOV
35 hedge funds and large institutions have $6.78M invested in MediciNova in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 4 closing their positions.
500% more call options, than puts
Call options by funds: $18K | Put options by funds: $3K
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
3% more funds holding
Funds holding: 34 → 35 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.33% less ownership
Funds ownership: 9.86% → 9.53% (-0.33%)
7% less capital invested
Capital invested by funds: $7.25M → $6.78M (-$473K)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$79.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$37.2K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.57K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$142K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$63.7K |
| 3 |
Bank of New York Mellon
New York
|
-$33.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$27.7K |
MNOV Hedge Fund Activity: Q1 2024 in Review
35 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2024, worth a combined $6.78M — down 6.5% from $7.25M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MNOV positions and 4 closed out — a net gain of 1 holder — while 6 added to existing stakes and 13 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $79.9K. The largest seller was JP Morgan Chase, cutting an estimated $142K.
- 35 institutional investors held MediciNova (MNOV) as of Q1 2024, up from 34 in Q4 2023.
- Funds reported $6.78M of MediciNova stock for Q1 2024, down 6.5% quarter-over-quarter.
- 5 funds opened new MediciNova positions in Q1 2024 and 4 closed out, a net change of +1 holder.
- The largest MediciNova buyer in Q1 2024 was Renaissance Technologies, an estimated $79.9K added.
- The largest MediciNova seller in Q1 2024 was JP Morgan Chase, an estimated $142K sold.
Based on aggregated 13F filings for Q1 2024.